The Food and Drug Administration on Monday approved updated COVID-19 vaccinations aimed at more closely matching currently circulating strains of the virus.

“The public can be assured that these updated vaccines have met the agency’s rigorous scientific standards for safety, effectiveness, and manufacturing quality," said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.

CLICK HERE TO READ MORE FROM THE WASHINGTON EXAMINER

Earlier this summer, the FDA's Vaccines and Related Biological Products Advisory Committee met to recommend that vaccine manufacturers produce a product targeted at the omicron XBB 1.5 variant.

This is a developing story and will be updated.